VIR (STOCKS)
Vir Biotechnology, Inc. Common Stock
$9.251200
-0.248800 (-2.62%)
Prev close: $9.500000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Marianne de Backer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,487.04M
- Employees
- 408
- P/E (TTM)
- -2.94
- P/B (TTM)
- 1.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.31 | $-0.50 | +0.1865 | +37.56% |
|
Sep 2025 (Q3)
|
$-1.17 | $-0.86 | -0.3078 | -35.70% |
|
Jun 2025 (Q2)
|
$-0.80 | $-0.73 | -0.0693 | -9.48% |
|
Mar 2025 (Q1)
|
$-0.88 | $-0.84 | -0.0359 | -4.25% |
Financial Statements
| Revenues | $68.56M |
| Benefits Costs and Expenses | $506.33M |
| Cost Of Revenue | $26.00K |
| Costs And Expenses | $547.88M |
| Gross Profit | $68.53M |
| Nonoperating Income/Loss | $41.56M |
| Operating Expenses | $547.86M |
| Selling, General, and Administrative Expenses | $92.07M |
| Research and Development | $455.97M |
| Operating Income/Loss | -$479.33M |
| Income/Loss From Continuing Operations After Tax | -$437.99M |
| Income/Loss From Continuing Operations Before Tax | -$437.77M |
| Income Tax Expense/Benefit | $217.00K |
| Income Tax Expense/Benefit, Current | -$87.00K |
| Income Tax Expense/Benefit, Deferred | $304.00K |
| Net Income/Loss | -$437.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$437.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$437.99M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.16 |
| Diluted Earnings Per Share | -$3.16 |
| Basic Average Shares | 138,520,419 |
| Diluted Average Shares | 138,520,419 |
| Assets | $1.00B |
| Current Assets | $514.08M |
| Noncurrent Assets | $488.74M |
| Fixed Assets | $55.62M |
| Intangible Assets | $7.85M |
| Other Non-current Assets | $425.27M |
| Liabilities | $237.55M |
| Current Liabilities | $92.82M |
| Accounts Payable | $9.80M |
| Other Current Liabilities | $83.01M |
| Noncurrent Liabilities | $144.73M |
| Equity | $765.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $765.28M |
| Liabilities And Equity | $1.00B |
| Net Cash Flow From Operating Activities | -$391.78M |
| Net Cash Flow From Operating Activities, Continuing | -$391.78M |
| Net Cash Flow From Investing Activities | $310.37M |
| Net Cash Flow From Investing Activities, Continuing | $310.37M |
| Net Cash Flow From Financing Activities | $3.79M |
| Net Cash Flow From Financing Activities, Continuing | $3.79M |
| Net Cash Flow | -$77.63M |
| Net Cash Flow, Continuing | -$77.63M |
| Comprehensive Income/Loss | -$438.33M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$438.33M |
| Other Comprehensive Income/Loss | -$340.00K |